These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32792296)

  • 1. [French Health Authority certification visit in a radiotherapy department].
    Ponsard N; Heddadi L; Pradier O
    Cancer Radiother; 2020 Oct; 24(6-7):722-725. PubMed ID: 32792296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality/risk management system in radiotherapy: Changes afoot.
    Pourel N; Meyrieux C; Lisbona A
    Cancer Radiother; 2022; 26(1-2):14-19. PubMed ID: 34953695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Recommendations for inspections of the French nuclear safety authority].
    Rousse C; Chauvet B;
    Cancer Radiother; 2015 Oct; 19(6-7):634-7. PubMed ID: 26321685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [How to prepare for the V2020 certification visit by the French Health Authority in a maternity ward?].
    Vendittelli F
    Gynecol Obstet Fertil Senol; 2022 May; 50(5):409-414. PubMed ID: 35124275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Not Available].
    Keribin L; Grenier C; de Saxcé AA
    Soins; 2018 Oct; 63(829):20-22. PubMed ID: 30366697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Not Available].
    Franzin-Garrec M; Huin C; Pernot B; Prudhomme V
    Soins; 2018 Oct; 63(829):42-45. PubMed ID: 30366703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Project management of the implementation of intracranial stereotactic body radiotherapy at the "Centre finistérien de radiothérapie et d'oncologie"].
    Ponsard N; Lasserre L; Caradec A; Couppa É
    Cancer Radiother; 2019 Oct; 23(6-7):523-525. PubMed ID: 31444077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recommendation of the working group commissioned by the French Nuclear Safety Authority on stereotactic radiation therapy].
    Gérard JP; Aubert B; Buchheit I; Derreumaux S; Lartigau E; Latorzeff I; Lisbona A; Marinello G; Ménéchal P; Porcheron D; Zeghari Squalli N; Isambert A;
    Cancer Radiother; 2012 Jun; 16 Suppl():S5-9. PubMed ID: 22578900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The control of radiation protection in the field of radiotherapy by the French Nuclear Safety Authority (ASN)].
    Godet JL
    Cancer Radiother; 2007 Nov; 11(6-7):313-6. PubMed ID: 17962062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Epinal radiotherapy accident: passed, present, future].
    Peiffert D; Simon JM; Eschwege F
    Cancer Radiother; 2007 Nov; 11(6-7):309-12. PubMed ID: 17962063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Risk analysis in radiation therapy: state of the art].
    Mazeron R; Aguini N; Deutsch É
    Cancer Radiother; 2013; 17(4):308-16, quiz 332. PubMed ID: 23787020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Certification of health-related websites in France].
    Nabarette H; Romaneix F; Boyer C; Darmoni SJ; Rémy PL; Caniard E
    Presse Med; 2009 Oct; 38(10):1476-83. PubMed ID: 19665341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [From Crex mutualisation to clinical audit].
    Debouck F; Petit HB; Lartigau E
    Cancer Radiother; 2010 Oct; 14(6-7):571-5. PubMed ID: 20729118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Certification assessment and quality and risk management].
    Papin-Morardet M
    Rev Infirm; 2018 Mar; 67(239):16-20. PubMed ID: 29525006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Guide for external beam radiotherapy. Procedures 2007].
    Ortholan C; Estivalet S; Barillot I; Costa A; Gérard JP;
    Cancer Radiother; 2007 Nov; 11(6-7):329-30. PubMed ID: 17962059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [French National Authority for Health].
    Huguier M; Rossignol C
    Bull Acad Natl Med; 2013 Oct; 197(7):1409-18. PubMed ID: 25796732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [AFQSR: A concrete and active implication in the service of the radiotherapy in 2018].
    Ponsard N
    Cancer Radiother; 2018 Oct; 22(6-7):537-539. PubMed ID: 30150088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A quality indicator can be biased by intra-hospital heterogeneity: the case for quality of patient record keeping in France.
    Lelong A; Léger S; Vendittelli F; Blanquet M; Thuong CT; Belgacem B; Gerbaud L
    Eur J Public Health; 2015 Oct; 25(5):787-91. PubMed ID: 25983328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Quality and safety policy implementation for a new radiotherapy device].
    Martin C; Jumeau R; Blais E; Canova CH; Klausner G; Dumas R; Rouger A; Pariente F; Lyothier A; Slama Y; Dol J; Perret J; Jenny C; Chea M; Pasdeloup F; Maingon P; Troussier I
    Cancer Radiother; 2019 Feb; 23(1):50-57. PubMed ID: 30558863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The quality manager in radiation therapy: Evolution of the role, presentation of a French national Survey].
    Brusadin G; Cucchiaro S; Nardin S; Leroy É
    Cancer Radiother; 2023 Sep; 27(6-7):573-576. PubMed ID: 37482462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.